211 related articles for article (PubMed ID: 19878920)
1. Clinical benefits of the Boston Ocular Surface Prosthesis.
Stason WB; Razavi M; Jacobs DS; Shepard DS; Suaya JA; Johns L; Rosenthal P
Am J Ophthalmol; 2010 Jan; 149(1):54-61. PubMed ID: 19878920
[TBL] [Abstract][Full Text] [Related]
2. Economic appraisal of the Boston Ocular Surface Prosthesis.
Shepard DS; Razavi M; Stason WB; Jacobs DS; Suaya JA; Cohen M; Rosenthal P
Am J Ophthalmol; 2009 Dec; 148(6):860-8.e2. PubMed ID: 19781684
[TBL] [Abstract][Full Text] [Related]
3. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
[TBL] [Abstract][Full Text] [Related]
4. The impact of the Boston ocular surface prosthesis on wavefront higher-order aberrations.
Gumus K; Gire A; Pflugfelder SC
Am J Ophthalmol; 2011 Apr; 151(4):682-690.e2. PubMed ID: 21269603
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitrectomy for epiretinal membrane on visual function and vision-related quality of life.
Okamoto F; Okamoto Y; Hiraoka T; Oshika T
Am J Ophthalmol; 2009 May; 147(5):869-74, 874.e1. PubMed ID: 19200531
[TBL] [Abstract][Full Text] [Related]
6. The relation between visual performance and clinical ocular manifestations in Stevens-Johnson syndrome.
Kaido M; Yamada M; Sotozono C; Kinoshita S; Shimazaki J; Tagawa Y; Hara Y; Chikama T; Tsubota K
Am J Ophthalmol; 2012 Sep; 154(3):499-511.e1. PubMed ID: 22818907
[TBL] [Abstract][Full Text] [Related]
7. Intracorneal ring segment implantation in corneas with post-laser in situ keratomileusis keratectasia.
Piñero DP; Alio JL; Uceda-Montanes A; El Kady B; Pascual I
Ophthalmology; 2009 Sep; 116(9):1665-74. PubMed ID: 19643485
[TBL] [Abstract][Full Text] [Related]
8. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
[TBL] [Abstract][Full Text] [Related]
9. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
Cahill MT; Banks AD; Stinnett SS; Toth CA
Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
[TBL] [Abstract][Full Text] [Related]
10. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
Cahill MT; Stinnett SS; Banks AD; Freedman SF; Toth CA
Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
[TBL] [Abstract][Full Text] [Related]
11. Vision-related quality of life in patients with pituitary adenoma.
Okamoto Y; Okamoto F; Hiraoka T; Yamada S; Oshika T
Am J Ophthalmol; 2008 Aug; 146(2):318-322. PubMed ID: 18538298
[TBL] [Abstract][Full Text] [Related]
12. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Papakostas TD; Le HG; Chodosh J; Jacobs DS
Ophthalmology; 2015 Feb; 122(2):248-53. PubMed ID: 25282251
[TBL] [Abstract][Full Text] [Related]
13. Refractive and corneal aberrometric changes after intracorneal ring implantation in corneas with pellucid marginal degeneration.
Piñero DP; Alio JL; Morbelli H; Uceda-Montanes A; El Kady B; Coskunseven E; Pascual I
Ophthalmology; 2009 Sep; 116(9):1656-64. PubMed ID: 19643482
[TBL] [Abstract][Full Text] [Related]
14. A comparison of synergeyes versus traditional rigid gas permeable lens designs for patients with irregular corneas.
Nau AC
Eye Contact Lens; 2008 Jul; 34(4):198-200. PubMed ID: 18787425
[TBL] [Abstract][Full Text] [Related]
15. Vision-related quality of life in patients suffering from age-related macular degeneration.
Berdeaux GH; Nordmann JP; Colin E; Arnould B
Am J Ophthalmol; 2005 Feb; 139(2):271-9. PubMed ID: 15733988
[TBL] [Abstract][Full Text] [Related]
16. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia.
DeLoss KS; Fatteh NH; Hood CT
Am J Ophthalmol; 2014 Nov; 158(5):974-82. PubMed ID: 25058902
[TBL] [Abstract][Full Text] [Related]
17. Scleral lenses in the management of ocular surface disease.
Schornack MM; Pyle J; Patel SV
Ophthalmology; 2014 Jul; 121(7):1398-405. PubMed ID: 24630687
[TBL] [Abstract][Full Text] [Related]
18. Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy.
Okamoto F; Okamoto Y; Fukuda S; Hiraoka T; Oshika T
Am J Ophthalmol; 2008 Jun; 145(6):1031-1036. PubMed ID: 18400203
[TBL] [Abstract][Full Text] [Related]
19. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
20. Vision- and health-related quality of life in patients with visual field loss after postchiasmatic lesions.
Gall C; Lucklum J; Sabel BA; Franke GH
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2765-76. PubMed ID: 19117930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
